Related Experiment Videos
Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation
1nimal Genomics, AgResearch, Private Bag 3123, East St., Hamilton 2001, New Zealand.
Abstract:
Myostatin, a member of the transforming growth factor-beta (TGF-beta) superfamily, has been shown to be a negative regulator of myogenesis. Here we show that myostatin functions by controlling the proliferation of muscle precursor cells. When C(2)C(12) myoblasts were incubated with myostatin, proliferation of myoblasts decreased with increasing levels of myostatin. Fluorescence-activated cell sorting analysis revealed that myostatin prevented the progression of myoblasts from the G(1)- to S-phase of the cell cycle. Western analysis indicated that myostatin specifically up-regulated p21(Waf1, Cip1), a cyclin-dependent kinase inhibitor, and decreased the levels and activity of Cdk2 protein in myoblasts. Furthermore, we also observed that in myoblasts treated with myostatin protein, Rb was predominately present in the hypophosphorylated form. These results suggests that, in response to myostatin signaling, there is an increase in p21 expression and a decrease in Cdk2 protein and activity thus resulting in an accumulation of hypophosphorylated Rb protein. This, in turn, leads to the arrest of myoblasts in G(1)-phase of cell cycle. Thus, we propose that the generalized muscular hyperplasia phenotype observed in animals that lack functional myostatin could be as a result of deregulated myoblast proliferation.
Insights
Myostatin inhibits muscle precursor cell proliferation by arresting them in the G1 phase of the cell cycle. This occurs through increased p21 expression and decreased Cdk2 activity, impacting Rb protein phosphorylation.
Area of Science:
- Muscle biology
- Cell cycle regulation
- Molecular signaling
Background:
- Myostatin, a TGF-beta superfamily member, negatively regulates myogenesis.
- Understanding myostatin's precise mechanism in muscle development is crucial.
Purpose of the Study:
- To elucidate the role of myostatin in controlling muscle precursor cell proliferation.
- To investigate the molecular pathways by which myostatin affects the cell cycle.
Main Methods:
- Incubation of C(2)C(12) myoblasts with varying concentrations of myostatin.
- Fluorescence-activated cell sorting (FACS) analysis for cell cycle progression.
- Western blot analysis to assess protein levels and activity (p21, Cdk2, Rb).
Main Results:
- Myostatin significantly decreased myoblast proliferation in a dose-dependent manner.
- Myostatin treatment led to cell cycle arrest at the G1 to S-phase transition.
- Key molecular changes included upregulation of p21(Waf1, Cip1), downregulation of Cdk2, and accumulation of hypophosphorylated Rb protein.
Conclusions:
- Myostatin enforces G1 cell cycle arrest in myoblasts via p21 and Cdk2 regulation.
- This mechanism explains how myostatin controls muscle precursor cell proliferation.
- Disruption of this pathway may underlie the muscular hyperplasia observed in myostatin-deficient states.